Martha Kingman, FNP-C, DNP, and Bradley A. Maron, MD, review the latest guidelines and best practices for the primary care provider in the diagnosis and management of pulmonary arterial hypertension and...
This COVID-19 roundup includes coverage on the FDA-approved oral antiviral treatment for adults with mild-to-moderate COVID-19, how antidepressant medication may lower the incidence of COVID-19, a study...
Following a multicenter clinical trial, a new treatment for pneumonia caused by Acinetobacter baumannii-calcoaceticus has been approved for use in adults.
The American Thoracic Society released a set of guidelines addressing the use of pulmonary rehabilitation in patients with chronic obstructive pulmonary disorder and other respiratory diseases.
Following three clinical trials, the FDA has approved a new preventive treatment for neonates, infants, and toddlers that prevents respiratory syncytial virus (RSV) in those age populations.
This COVID-19 roundup includes coverage of the FDA’s simpler vaccination schedule and authorization of new treatment, decline in pediatric asthma diagnoses during pandemic, and a new treatment combination...
Researchers determined the risk of death and health care costs in patients with COPD who undergo surgery compared with patients without COPD who undergo surgery.
Following a multicenter study, the FDA approved the combination of albuterol and budesonide—an inhaled corticosteroid—for the treatment of asthma in adults.
